Active Ingredient (In Each Tablet)
Guaifenesin 400 mg
The following Structured Product Label (SPL) was submitted to the FDA by Zennova Llc for the product Guaifenesin (NDC 81993-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, when using this product, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 400 mg
Expectorant
Temporary symptomatic relief from congested chests and cough.
A persistent cough maybe a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache, consult a doctor.
Do not use - For children under 12 years of age
if cough lasts more than 7 days, please consult your physician or healthcare provider.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
ask a health professional before use
Call toll free 1-888-572-7085, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Maltodextrin, Povidone K30, Colloidal Silicon Dioxide, Silicon Dioxide, Stearic Acid
* Please review the disclaimer below.